Ligand Pharmaceuticals Incorporated Insider Transactions
Ligand Pharmaceuticals Incorporated Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Espinoza Octavio
CFO |
Sell | 5,000 @ $115.03 | $575.15 K | 18,879 | 03/04/2025 | 03/06/2025 | |
Espinoza Octavio
CFO |
Sell | 2,104 @ $116.37 | $244.85 K | 20,647 | 12/23/2024 | 12/26/2024 | |
LAMATTINA JOHN L
Director |
Sell | 2,406 @ $123.65 | $297.50 K | 29,515 | 11/27/2024 | 12/02/2024 | |
Korenberg Matthew E
President & COO |
Sell | 7,090 @ $101.61 | $720.38 K | 50,978 | 09/23/2024 | 09/24/2024 | |
Reardon Andrew
CLO & Secretary |
Sell | 2,000 @ $99.60 | $199.20 K | 22,534 | 09/23/2024 | 09/25/2024 | |
Korenberg Matthew E
President & COO |
Sell | 2,481 @ $100.05 | $248.23 K | 58,068 | 09/23/2024 | 09/24/2024 | |
Korenberg Matthew E
President & COO |
Sell | 201 @ $102.05 | $20.51 K | 50,777 | 09/23/2024 | 09/24/2024 | |
Espinoza Octavio
CFO |
Sell | 200 @ $103.98 | $20.80 K | 25,685 | 09/20/2024 | 09/24/2024 | |
Korenberg Matthew E
President & COO |
Sell | 6,275 @ $104.10 | $653.24 K | 50,777 | 09/20/2024 | 09/24/2024 | |
Espinoza Octavio
CFO |
Sell | 275 @ $103.86 | $28.56 K | 25,410 | 09/20/2024 | 09/24/2024 | |
Espinoza Octavio
CFO |
Sell | 800 @ $103.95 | $83.16 K | 24,610 | 09/20/2024 | 09/24/2024 | |
Reardon Andrew
CLO & Secretary |
Sell | 1,500 @ $106.39 | $159.59 K | 22,534 | 08/28/2024 | 08/30/2024 | |
Korenberg Matthew E
President & COO |
Sell | 6,177 @ $105.02 | $648.68 K | 54,722 | 08/26/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 5,212 @ $106.32 | $554.15 K | 49,510 | 08/26/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 2,037 @ $104.09 | $212.04 K | 65,174 | 08/23/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 4,275 @ $105.13 | $449.44 K | 60,899 | 08/23/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 1,157 @ $105.54 | $122.11 K | 67,211 | 08/22/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 18,245 @ $98.50 | $1.80 M | 68,368 | 08/09/2024 | 08/13/2024 | |
Davis Todd C
CEO |
Buy | 2,500 @ $97.39 | $243.48 K | 123,010 | 08/08/2024 | 08/09/2024 | |
Espinoza Octavio
CFO |
Sell | 5,022 @ $86.67 | $435.23 K | 23,513 | 05/17/2024 | 05/17/2024 |
Ligand Pharmaceuticals Incorporated FAQ's
The list of insiders at Ligand Pharmaceuticals Incorporated includes Espinoza Octavio, Davis Todd C, Korenberg Matthew E, Reardon Andrew, LAMATTINA JOHN L.
Insiders have sold a total of 78.46 K Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 7.99 M sold.
The following insiders have sold Ligand Pharmaceuticals Incorporated shares in the last 12 months: Espinoza Octavio ($1.90 M), Korenberg Matthew E ($5.43 M), Reardon Andrew ($358.79 K), LAMATTINA JOHN L ($297.50 K),
Insiders have purchased a total of 2.50 K Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 243.48 K.
The following insiders have purchased Ligand Pharmaceuticals Incorporated shares in the last 12 months: Davis Todd C ($243.48 K),